Yariv Houvras

Director Técnico/Científico/I+D en XILIO THERAPEUTICS, INC. .

Consumer Services

Health Technology

Perfil

Dr. Yariv J.
Houvras is a Chief Medical Officer at Xilio Therapeutics, Inc. Dr. Houvras was previously employed as a SVP-Clinical & Translational Development by Tubulis GmbH.
He received his undergraduate degree from the University of Michigan and a doctorate degree from Icahn School of Medicine at Mount Sinai.

Cargos activos de Yariv Houvras

Empresas	Cargo	Inicio
XILIO THERAPEUTICS, INC.	Director Técnico/Científico/I+D	28/09/2026

Todos los cargos activos de Yariv Houvras

Antiguos cargos conocidos de Yariv Houvras.

Empresas	Cargo	Fin
Tubulis GmbH Tubulis GmbH BiotechnologyHealth Technology Develops and manufactures antibody-drug conjugates with biophysical properties to treat cancer tumors	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Yariv Houvras.

Formación de Yariv Houvras.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Yariv Houvras.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
University of Michigan University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Icahn School of Medicine at Mount Sinai Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Xilio Therapeutics, Inc. Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies	Health Technology
Tubulis GmbH Tubulis GmbH BiotechnologyHealth Technology Develops and manufactures antibody-drug conjugates with biophysical properties to treat cancer tumors	Health Technology